Trial intelligence / Profile preview

Coated Nifedipine Suppository for Chronic Anal Fissure

NCT00972907Phase 2Completed

Sponsor
RDD Pharma
Start
Dec 2009
Primary completion
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nifedipine in chronic anal fissure (CAF), sponsored by RDD Pharma. Started Dec 2009; status: completed.

02

Drugs

nifedipine
03

Conditions

chronic anal fissure (CAF)

Beyond the preview

Go deeper on NCT00972907.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00972907.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call